Method and therapeutic agent for treatment of HTLV-1-related myelopathy patients

• 收藏
• 分享

专利权人:

学校法人;聖マリアンナ医科大学;学校法人 聖マリアンナ医科大学;協和発酵キリン株式会社

发明人:

山野 嘉久

申请号：

JP2014523774

公开号：

JP6310845B2

申请日:

2013.07.03

申请国别(地区):

JP

年份:

2018

代理人:

摘要：

The object of the present invention is to provide a new therapeutic method and a new therapeutic agent that are different from known therapeutic medicines for human T cell leukemia virus type-1 associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers. The present invention relates to a therapeutic method and a therapeutic agent for human T cell leukemia virus type-1(HTLV-1) associated myelopathy (HAM) patients and asymptomatic HTLV-1 carriers (ACs), which is characterized by reducing HTLV-1 virus-infected cells using an anti-human CC-chemokine receptor 4 (CCR4) antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/